Opemalirsen sodium is an antisense oligonucleotide targeted to apolipoprotein L1 (APOL1). It is used for the study of Kidney disorders.
References:
[1]. Mahajan S, Zhao H, Kovacina K, et al. High-sensitivity quantification of antisense oligonucleotides for pharmacokinetic characterization. Bioanalysis. 2022;14(9):603-613.
References:
[1]. Mahajan S, Zhao H, Kovacina K, et al. High-sensitivity quantification of antisense oligonucleotides for pharmacokinetic characterization. Bioanalysis. 2022;14(9):603-613.
















